Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Ambrx Biopharma Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/10/2023 8-K Quarterly results
10/06/2023 8-K Resignation/termination of a director
08/25/2023 8-K Other Events  Interactive Data
06/28/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Ambrx Announces Closing of $75 Million Market Priced Registered Offering SAN DIEGO"
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/25/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Opinion of Maples & Calder (Hong Kong) LLP",
"Securities Purchase Agreement, by and between Ambrx Biopharma Inc. and the Purchasers",
"Ambrx Announces $75 Million Market Priced Registered Offering"
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Ambrx Appoints Stephen Glover as Chairman of its Board of Directors"
05/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Executive Employment Agreement by and between the Company and Daniel J. O’Connor",
"Amendment to Executive Employment Agreement by and between the Company and Daniel J. O’Connor"
05/04/2023 8-K Quarterly results
03/13/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Ambrx Raises $78 Million and Completes its ATM Program"
03/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Ambrx to Commence Trading on Nasdaq"
03/01/2023 8-K Quarterly results
02/24/2023 8-K Resignation/termination of a director
Docs: "Analyst and Investor Day Presentation",
"Analyst and Investor Day Presentation"
02/06/2023 8-K Results of Operations and Financial Condition, Other Events  Interactive Data
01/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy